Risk factors for hypocalcemia following drug administration using multivariable analysis and adjusted for pretreatment serum calcium level, eGFR on admission, age, sex, PTH level on admission, and the administration of denosumab. The gene discussed is PTH; the disease is Hypocalcemia.